Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Solid Tumor, Adult × osimertinib × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 19 Lung Neoplasms 11 Neoplasms 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Lymphoma 2 Hematologic Neoplasms 2 Breast Neoplasms 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Stage IB-IIIA Non-small Cell Lung Carcinoma 1 Squamous Cell Carcinoma of Head and Neck 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Non Small Cell Lung Cancer Metastatic 1 Multiple Endocrine Neoplasia Type 2a 1 Mesothelioma 1 Melanoma 1 Lethal Congenital Contracture Syndrome 2 1 Glioma 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Colorectal Neoplasms 1

Interventions

pembrolizumab 3 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡